Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)

The role of soluble suppression of tumorigenicity (sST2) as a biomarker in predicting clinical outcomes in patients with cardiovascular diseases (CVD) has not been fully elucidated. In this study, we sought to determine the relationship between sST2 levels and any unplanned hospital readmissions due...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dongqing, Untaru, Rossana, Stavropoulou, Glykeria, Assadi-Khansari, Bahador, Kelly, Conagh, Croft, Amanda J., Sugito, Stuart, Collins, Nicholas J., Sverdlov, Aaron L., Ngo, Doan T. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142832/
https://www.ncbi.nlm.nih.gov/pubmed/37109127
http://dx.doi.org/10.3390/jcm12082790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142832/
https://www.ncbi.nlm.nih.gov/pubmed/37109127
http://dx.doi.org/10.3390/jcm12082790

Ejemplares similares